These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 20077524)
21. Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Shen J; Sun M; Ping Q; Ying Z; Liu W Nanotechnology; 2010 Jan; 21(2):025101. PubMed ID: 19955616 [TBL] [Abstract][Full Text] [Related]
22. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Sanvicens N; Marco MP Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941 [TBL] [Abstract][Full Text] [Related]
23. Protein-based nanomedicine platforms for drug delivery. Maham A; Tang Z; Wu H; Wang J; Lin Y Small; 2009 Aug; 5(15):1706-21. PubMed ID: 19572330 [TBL] [Abstract][Full Text] [Related]
24. Charged nanoparticles delivery to the eye using hydrogel iontophoresis. Eljarrat-Binstock E; Orucov F; Aldouby Y; Frucht-Pery J; Domb AJ J Control Release; 2008 Mar; 126(2):156-61. PubMed ID: 18201790 [TBL] [Abstract][Full Text] [Related]
25. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233 [TBL] [Abstract][Full Text] [Related]
27. Viruses as nanomaterials for drug delivery. Lockney D; Franzen S; Lommel S Methods Mol Biol; 2011; 726():207-21. PubMed ID: 21424452 [TBL] [Abstract][Full Text] [Related]
28. [Targeted nanomedicine in diagnostics and therapy of neurological diseases]. Bertalan F; László B; Attila V Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015 [TBL] [Abstract][Full Text] [Related]
29. Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy. Zharov VP; Kim JW; Curiel DT; Everts M Nanomedicine; 2005 Dec; 1(4):326-45. PubMed ID: 17292107 [TBL] [Abstract][Full Text] [Related]
30. [General and specific aspects of the toxic properties of nanoparticles and other chemical substances in the context of classical toxicology]. Zholdakova ZI; Sinitsyna OO; Kharchevnikova NV Gig Sanit; 2008; (6):12-6. PubMed ID: 19198250 [TBL] [Abstract][Full Text] [Related]
31. Nanomedicine: magnetic nanoparticles hit the target. Amirfazli A Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342 [No Abstract] [Full Text] [Related]
32. Chitosan nanoparticles for drug delivery to the eye. Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841 [TBL] [Abstract][Full Text] [Related]
33. Self-ordered nanopore and nanotube platforms for drug delivery applications. Losic D; Simovic S Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534 [TBL] [Abstract][Full Text] [Related]
34. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. Powell AC; Paciotti GF; Libutti SK Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609 [TBL] [Abstract][Full Text] [Related]
35. Nanomedicine: sizing up targets with nanoparticles. Minchin R Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442 [No Abstract] [Full Text] [Related]
36. Gelatin nanoparticles as a new and simple gene delivery system. Zwiorek K; Kloeckner J; Wagner E; Coester C J Pharm Pharm Sci; 2005 Feb; 7(4):22-8. PubMed ID: 15850545 [TBL] [Abstract][Full Text] [Related]
37. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548 [TBL] [Abstract][Full Text] [Related]
38. Nanomedicine and veterinary science: the reality and the practicality. Underwood C; van Eps AW Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842 [TBL] [Abstract][Full Text] [Related]